Promedigen
Daejeon
About Promedigen
Promedigen is a biotechnology company focusing on the treatment of cancer and neurodegenerative disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Last round: Series Unknown (Jan 2021)
- Website: promedigen.com
- Phone: +82 42 867 9113
Industries & Categories
Biotechnology, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/promedigen-2929927 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.